OUTREACH
Phase 1 Unknown
75 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
Phase 1/2 Unknown
42 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Phase 2 Unknown
5 enrolled
HCC
Phase 2/3 Unknown
405 enrolled
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Phase 1 Unknown
20 enrolled
NWRD06 DNA Plasmid for HCC After Radical Resection
Phase 1 Unknown
9 enrolled
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Phase 1 Unknown
26 enrolled
OASES
Phase 2 Unknown
33 enrolled
Polyvinyl Alcohol Embolization Microspheres
Phase NA Unknown
224 enrolled
SynOV1.1 Intratumoral Injection Study
Phase 1 Unknown
15 enrolled
GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)
Unknown
1,000 enrolled
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Phase 1 Unknown
78 enrolled
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC
Phase 3 Unknown
490 enrolled
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
Phase 1 Unknown
27 enrolled
A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients
Phase 2 Unknown
123 enrolled
DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria
Phase NA Unknown
100 enrolled
Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)
Phase 2 Unknown
72 enrolled
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
Phase 1/2 Unknown
50 enrolled
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
Phase 2/3 Unknown
595 enrolled
PIONEER
Unknown
1,000 enrolled
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
Phase 1 Unknown
39 enrolled
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
Phase 1 Unknown
90 enrolled
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Phase 2/3 Unknown
60 enrolled
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Phase 1 Unknown
9 enrolled
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Phase 1/2 Unknown
73 enrolled
A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Phase 1/2 Unknown
60 enrolled
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Phase 1 Unknown
140 enrolled
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Phase 1 Unknown
12 enrolled
Hepko-V5
Phase 3 Unknown
120 enrolled
Circulating Tumor DNA Exposure in Peripheral Blood
Unknown
10,000 enrolled
A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation
Phase 1 Unknown
10 enrolled
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Phase 1 Unknown
18 enrolled
Expanding Phase III Study of Tyroserleutide for Injection
Phase 3 Unknown
352 enrolled
PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images
Phase NA Unknown
20 enrolled
A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)
Phase 1/2 Unknown
10 enrolled
A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
Phase 1/2 Unknown
55 enrolled
Clemizole HCl for Subjects With Hepatocellular Carcinoma
Phase 2 Unknown
12 enrolled
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Phase 1/2 Unknown
10 enrolled
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
Phase 1/2 Unknown
20 enrolled
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Phase 1/2 Unknown
20 enrolled
ALTER0802
Phase 2 Unknown
60 enrolled
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
Phase 1 Unknown
18 enrolled
Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours
Phase NA Unknown
30 enrolled
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma
Phase 2 Unknown
60 enrolled
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
Phase 1 Unknown
112 enrolled
GPC3-CART
Phase 1/2 Unknown
30 enrolled
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
Phase 1 Unknown
40 enrolled
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
Phase 2 Unknown
15 enrolled